Secret Outlast Invisible description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Secret Outlast Invisible

Procter & Gamble Manufacturing Company

Secret Outlast™ InvisibleProtecting Powder


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredient

Aluminum zirconium tetrachlorohydrex Gly 19% (anhydrous)

Purpose

Antiperspirant

Use

reduces underarm wetness

Warnings

For external use only.

Do not use on broken skin

Ask a doctor before use if you have kidney disease

Stop use if rash or irritation occurs

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

apply to underarms only

Inactive ingredients

cyclopentasiloxane, stearyl alcohol, C12-15 alkyl benzoate, PPG-14 butyl ether, cyclodextrin, petrolatum, phenyl trimethicone, hydrogenated castor oil, talc, fragrance, ozokerite, behenyl alcohol, panthenyl triacetate, tocopheryl acetate, acetyl glucosamine

Questions?

1-800-964-1947

Dist. by PROCTER & GAMBLE,
CINCINNATI, OH 45202.

PRINCIPAL DISPLAY PANEL - 73 g Canister Label

INVISIBLE SOLID

Secret ®

OUTLAST

protecting
powder

ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY
ANTIPERSPIRANT/DEODORANT

NET WT. 2.6 OZ (73 g)

99867627

Secret Outlast Invisible

Secret Outlast Invisible

ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY STICK

Product Information

Product Type Human otc drug label Item Code (Source) NDC:37000-253
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
Aluminum Zirconium Tetrachlorohydrex GLY Aluminum Zirconium Tetrachlorohydrex GLY 0.19 g

Inactive Ingredients

Ingredient Name Strength
CYCLOMETHICONE 5
stearyl alcohol
ALKYL (C12-15) BENZOATE
PPG-14 Butyl Ether
petrolatum
PHENYL TRIMETHICONE
HYDROGENATED CASTOR OIL
talc
docosanol
PANTHENOL TRIACETATE, (+)-
.ALPHA.-TOCOPHEROL ACETATE
N-ACETYLGLUCOSAMINE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:37000-253-73 73 in 1 CANISTER

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part350 2012-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.